Results 211 to 220 of about 38,544 (277)

A 48-Week, Randomized Controlled Trial of Doravirine for Individuals With HIV and Obesity on Integrase Inhibitors and Tenofovir Alafenamide: The Do IT Study (ACTG A5391)

John R Koethe, Jordan E. Lake, Amy Kantor, Laura Smeaton, Kristine Erlandson, Laura Moran, Pablo Belaunzaran-Zamudio, Alan Landay, Rafael Campo, Paula Debroy, Jaclyn Bennet, Jane O'Halloran, Win Min Han, Oladapo Alli, Michael Leonard, Roy M. Gulick   +15 more
openalex   +1 more source

Phase 1 Evaluation of VH4524184, a Third-Generation Integrase Strand Transfer Inhibitor With an Enhanced Resistance Profile [PDF]

Luise E. Rogg, Mark Underwood, Nathan Hanan, José Castillo‐Mancilla, Lesley Kahl, Fiona Halliday, Gabriela Ghita, Jerry Jeffrey, Stuart Byrne, Tsukasa Onodera, Joseph Horton, Martin Gartland   +11 more
openalex   +1 more source

Structural Impact of Ex Vivo Resistance Mutations on HIV-1 Integrase Polymers Induced by Allosteric Inhibitors

Saira Montermoso, Grant Eilers, Audrey Allen, R. Sharp, Young Kyu Hwang, Frederic D. Bushman, Kushol Gupta, Gregory Van Duyne   +7 more
openalex   +1 more source

Temporary increase in circulating replication-competent latent HIV-infected resting CD4+ T cells after switch to an integrase inhibitor based antiretroviral regimen. [PDF]

EBioMedicine
Ferreira RC, Reynolds SJ, Capoferri AA, Baker OR, Brown EE, Klock E, Miller J, Lai J, Saraf S, Kirby C, Lynch B, Hackman J, Gowanlock SN, Tomusange S, Jamiru S, Anok A, Kityamuweesi T, Buule P, Bruno D, Martens C, Rose R, Lamers SL, Galiwango RM, Poon AFY, Quinn TC, Prodger JL, Redd AD.   +26 more
europepmc   +1 more source

HIV-1 resistance and virological failure to treatment with the integrase inhibitors bictegravir, cabotegravir, and dolutegravir: a systematic literature review [PDF]

Antonio Arjona Castro, Carlos Rubio-Terrés, Darío Rubio-Rodríguez, José L. Blanco-Arévalo, Manuel Vélez‐Díaz‐Pallarés, Miguel García Deltoro, Miguel Torralba   +6 more
openalex   +1 more source